Hamilton Lane Inc. (NASDAQ:HLNE – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday . The company traded as low as $84.05 and last traded at $84.11, with a volume of 554658 shares traded. The stock had previously closed at $86.75.
Analysts Set New Price Targets
Several brokerages have weighed in on HLNE. Weiss Ratings reissued a “hold (c+)” rating on shares of Hamilton Lane in a research note on Thursday, January 22nd. Oppenheimer reduced their price objective on Hamilton Lane from $230.00 to $171.00 and set an “outperform” rating on the stock in a research note on Monday, April 13th. Zacks Research cut Hamilton Lane from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. UBS Group cut their target price on Hamilton Lane from $184.00 to $150.00 and set a “buy” rating on the stock in a research note on Friday, February 20th. Finally, BMO Capital Markets cut their target price on Hamilton Lane from $148.00 to $118.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 24th. Six investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $153.13.
Read Our Latest Analysis on HLNE
Hamilton Lane Stock Down 3.0%
Institutional Trading of Hamilton Lane
A number of large investors have recently modified their holdings of HLNE. Royal Bank of Canada boosted its holdings in shares of Hamilton Lane by 6.0% in the first quarter. Royal Bank of Canada now owns 52,466 shares of the company’s stock valued at $7,800,000 after purchasing an additional 2,948 shares during the period. Jones Financial Companies Lllp boosted its holdings in shares of Hamilton Lane by 4,806.7% in the first quarter. Jones Financial Companies Lllp now owns 5,103 shares of the company’s stock valued at $759,000 after purchasing an additional 4,999 shares during the period. Geneos Wealth Management Inc. boosted its holdings in shares of Hamilton Lane by 196.9% in the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $57,000 after purchasing an additional 254 shares during the period. First Trust Advisors LP boosted its holdings in shares of Hamilton Lane by 26.7% in the second quarter. First Trust Advisors LP now owns 31,483 shares of the company’s stock valued at $4,474,000 after purchasing an additional 6,636 shares during the period. Finally, Amundi boosted its holdings in shares of Hamilton Lane by 39,766.7% in the second quarter. Amundi now owns 2,392 shares of the company’s stock valued at $347,000 after purchasing an additional 2,386 shares during the period. Hedge funds and other institutional investors own 97.40% of the company’s stock.
Hamilton Lane Company Profile
Hamilton Lane is a global private markets investment management firm specializing in the full spectrum of private equity and credit strategies. The company partners with institutional investors and wealth managers to design, implement and manage customized portfolios in primary fund investing, secondary market transactions and direct co-investment opportunities. By combining investment selection, portfolio construction and ongoing monitoring, Hamilton Lane seeks to optimize risk-adjusted returns across diverse private markets exposures.
Founded in 1991, Hamilton Lane has developed a track record of investment and advisory services in private markets.
Featured Articles
- Five stocks we like better than Hamilton Lane
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.
